
    
      The objective of this study was to assess the safety and efficacy of eculizumab in Japanese
      patients with hemolytic PNH. In addition, the pharmacokinetics (PK) and pharmacodynamics (PD)
      of eculizumab in Japanese patients were assessed and compared to that of non-Japanese
      patients who had participated earlier studies of eculizumab treatment in hemolytic PNH.
    
  